These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Skardal A; Devarasetty M; Forsythe S; Atala A; Soker S Biotechnol Bioeng; 2016 Sep; 113(9):2020-32. PubMed ID: 26888480 [TBL] [Abstract][Full Text] [Related]
24. A thermoplastic microfluidic microphysiological system to recapitulate hepatic function and multicellular interactions. Bale SS; Manoppo A; Thompson R; Markoski A; Coppeta J; Cain B; Haroutunian N; Newlin V; Spencer A; Azizgolshani H; Lu M; Gosset J; Keegan P; Charest JL Biotechnol Bioeng; 2019 Dec; 116(12):3409-3420. PubMed ID: 30963546 [TBL] [Abstract][Full Text] [Related]
25. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology. Watson DE; Hunziker R; Wikswo JP Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799 [TBL] [Abstract][Full Text] [Related]
26. Promises, challenges and future directions of microCCAs. Esch MB; Sung JH; Shuler ML J Biotechnol; 2010 Jul; 148(1):64-9. PubMed ID: 20193719 [TBL] [Abstract][Full Text] [Related]
27. Atazanavir/ritonavir: a review of its use in HIV therapy. von Hentig N Drugs Today (Barc); 2008 Feb; 44(2):103-32. PubMed ID: 18389089 [TBL] [Abstract][Full Text] [Related]
28. Physiologically-Based Pharmacokinetic Modeling for Optimal Dosage Prediction of Quinine Coadministered With Ritonavir-Boosted Lopinavir. Saeheng T; Na-Bangchang K; Siccardi M; Rajoli RKR; Karbwang J Clin Pharmacol Ther; 2020 May; 107(5):1209-1220. PubMed ID: 31721171 [TBL] [Abstract][Full Text] [Related]
29. A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model. Lee H; Kim DS; Ha SK; Choi I; Lee JM; Sung JH Biotechnol Bioeng; 2017 Feb; 114(2):432-443. PubMed ID: 27570096 [TBL] [Abstract][Full Text] [Related]
30. Addressing a vascular endothelium array with blood components using underlying microfluidic channels. Genes LI; V Tolan N; Hulvey MK; Martin RS; Spence DM Lab Chip; 2007 Oct; 7(10):1256-9. PubMed ID: 17896007 [TBL] [Abstract][Full Text] [Related]
31. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications. Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219 [TBL] [Abstract][Full Text] [Related]
32. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617 [TBL] [Abstract][Full Text] [Related]
34. Liver microphysiological platforms for drug metabolism applications. Kulsharova G; Kurmangaliyeva A Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515 [TBL] [Abstract][Full Text] [Related]
35. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Maschmeyer I; Lorenz AK; Schimek K; Hasenberg T; Ramme AP; Hübner J; Lindner M; Drewell C; Bauer S; Thomas A; Sambo NS; Sonntag F; Lauster R; Marx U Lab Chip; 2015 Jun; 15(12):2688-99. PubMed ID: 25996126 [TBL] [Abstract][Full Text] [Related]
36. A Microfluidic Bioreactor for Toxicity Testing of Stem Cell Derived 3D Cardiac Bodies. Christoffersson J; Bergström G; Schwanke K; Kempf H; Zweigerdt R; Mandenius CF Methods Mol Biol; 2016; 1502():159-68. PubMed ID: 27052611 [TBL] [Abstract][Full Text] [Related]
37. Lopinavir/ritonavir: appraisal of its use in HIV therapy. von Hentig N Drugs Today (Barc); 2007 Apr; 43(4):221-47. PubMed ID: 17460785 [TBL] [Abstract][Full Text] [Related]
38. Cell-Based Assays on Microfluidics for Drug Screening. Liu X; Zheng W; Jiang X ACS Sens; 2019 Jun; 4(6):1465-1475. PubMed ID: 31074263 [TBL] [Abstract][Full Text] [Related]
39. The role of body-on-a-chip devices in drug and toxicity studies. Esch MB; King TL; Shuler ML Annu Rev Biomed Eng; 2011 Aug; 13():55-72. PubMed ID: 21513459 [TBL] [Abstract][Full Text] [Related]
40. Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience. van Heeswijk RP; Veldkamp A; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM Antivir Ther; 2001 Dec; 6(4):201-29. PubMed ID: 11878403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]